Chronic cathepsin inhibition by E-64 in Dahl salt-sensitive rats

Area of Science:

• Biochemistry
• Nephrology
• Cardiovascular Research

Background:

• Cysteine cathepsins are lysosomal enzymes crucial for protein metabolism.
• These enzymes are implicated in the progression of cardiovascular and renal diseases.
• Their specific role in salt-sensitive hypertension and kidney damage requires elucidation.

Purpose of the Study:

• To investigate the involvement of cysteine cathepsins in salt-sensitive hypertension.
• To assess the impact of cysteine cathepsin inhibition on hypertension-associated kidney damage.

Main Methods:

• Dahl salt-sensitive rats were fed a high-salt diet and treated with E-64, a cysteine cathepsin inhibitor, or a vehicle.
• Mean arterial pressure and albuminuria were monitored.
• Basal calcium levels in podocytes were measured using confocal calcium imaging.
• E-64 efficacy was confirmed via Western blotting.

Main Results:

• Both E-64 treated and control groups developed significant hypertension and kidney damage.
• No significant differences in mean arterial pressure or albuminuria were observed between groups.
• Basal calcium levels in podocytes remained unchanged, indicating no protective or aggravating effect of cathepsin inhibition.
• Western blotting confirmed E-64's inhibition of cysteine cathepsins B and L.

Conclusions:

• Inhibition of cysteine cathepsins with E-64 did not influence blood pressure or kidney damage in this salt-sensitive hypertension model.
• Cathepsin inhibition showed no discernible effect on podocyte calcium levels.
• The findings suggest cysteine cathepsins may not play a critical role in the development of SS hypertension under these experimental conditions.